Treatment of Influenza and ARVI in Children by Kagocel ®

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 11, 2015

Primary Completion Date

May 5, 2016

Study Completion Date

September 28, 2016

Conditions
InfluenzaAcute Upper Respiratory Infection
Interventions
DRUG

Kagocel

"The researchers prescribed antiviral medications, including Kagocel, according to routine clinical practice. Patients who were assigned Kagocel were invited to participate in the study.~Kagocel administration:~1. for children from 3 to 6 years old (n=41): In the first 2 days - 1 tablet 2 times a day, in the next 2 days - 1 tablet once a day. Total for the course of administration 6 tablets within the period of 4 days.~2. for children from 6 years old (n=39) - administered in the first 2 days - 1 tablet 3 times a day, in the next 2 days - 1 tablet 2 times a day. Total for the course of administration 10 tablets within the period of 4 days."

Trial Locations (1)

197022

Research Institute of Children's Infections of the Federal Medical and Biological Agency,, Saint Petersburg

All Listed Sponsors
lead

Nearmedic Plus LLC

INDUSTRY

NCT04651491 - Treatment of Influenza and ARVI in Children by Kagocel ® | Biotech Hunter | Biotech Hunter